1. Home
  2. ARCT vs MAX Comparison

ARCT vs MAX Comparison

Compare ARCT & MAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • MAX
  • Stock Information
  • Founded
  • ARCT 2013
  • MAX 2014
  • Country
  • ARCT United States
  • MAX United States
  • Employees
  • ARCT N/A
  • MAX N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • MAX Industrial Machinery/Components
  • Sector
  • ARCT Health Care
  • MAX Industrials
  • Exchange
  • ARCT Nasdaq
  • MAX Nasdaq
  • Market Cap
  • ARCT 487.0M
  • MAX 604.9M
  • IPO Year
  • ARCT N/A
  • MAX 2020
  • Fundamental
  • Price
  • ARCT $17.12
  • MAX $10.97
  • Analyst Decision
  • ARCT Strong Buy
  • MAX Buy
  • Analyst Count
  • ARCT 7
  • MAX 8
  • Target Price
  • ARCT $65.00
  • MAX $22.00
  • AVG Volume (30 Days)
  • ARCT 356.8K
  • MAX 448.4K
  • Earning Date
  • ARCT 03-06-2025
  • MAX 02-18-2025
  • Dividend Yield
  • ARCT N/A
  • MAX N/A
  • EPS Growth
  • ARCT N/A
  • MAX N/A
  • EPS
  • ARCT N/A
  • MAX 0.19
  • Revenue
  • ARCT $160,399,000.00
  • MAX $681,230,000.00
  • Revenue This Year
  • ARCT $7.33
  • MAX $124.41
  • Revenue Next Year
  • ARCT $4.71
  • MAX $31.11
  • P/E Ratio
  • ARCT N/A
  • MAX $58.16
  • Revenue Growth
  • ARCT N/A
  • MAX 72.47
  • 52 Week Low
  • ARCT $14.30
  • MAX $10.21
  • 52 Week High
  • ARCT $45.00
  • MAX $25.78
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 48.75
  • MAX 44.56
  • Support Level
  • ARCT $15.82
  • MAX $10.63
  • Resistance Level
  • ARCT $17.93
  • MAX $11.45
  • Average True Range (ATR)
  • ARCT 1.51
  • MAX 0.45
  • MACD
  • ARCT -0.04
  • MAX 0.04
  • Stochastic Oscillator
  • ARCT 23.90
  • MAX 44.66

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.

About MAX MediaAlpha Inc.

MediaAlpha Inc provides a platform that facilitates insurance carriers and distributors target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It acts as a customer acquisition channel in the areas of property & casualty insurance, health insurance, and life insurance. It operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.

Share on Social Networks: